TP53 and hepatocellular carcinoma: TP53 mutations account for about 30% of cases of HCC, while mutations in genes involved in WNT signaling (CTNNB1 and AXIN1) and chromatin remodeling (ARID1A) account for 27–40% [32,33,34,35].